Johnson & Johnson Completes Acquisition of Firefly Bio, Inc. to Advance Next-Generation Oncology Innovation Pharmaceutical Investing
Johnson & Johnson Announces Collaboration with Sail Biomedicines to Advance in vivo CAR-T Programs and Transform Autoimmune Disease Through Immune Reset Pharmaceutical Investing
European Commission Authorizes Pfizer and BioNTech XFG-adapted COVID-19 Vaccine in the European Union Pharmaceutical Investing
Dyne Therapeutics Reports Second Quarter 2026 Financial Results and Recent Business Highlights Life Science Investing
KORU Medical Systems to Participate in the Canaccord Genuity 46th Annual Growth Conference Life Science Investing
HCW Biologics Inc. Announces Pricing of $1.6 Million Private Placement Offering Life Science Investing
RenovoRx to Host Second Quarter 2026 Financial Results and Business Highlights Conference Call on August 12th at 4:30 p.m. ET Life Science Investing
Candel Therapeutics to Present at Canaccord Genuity's 46th Annual Growth Conference in Boston Life Science Investing
PharmaTher Collaborates with Craft Health to Evaluate CraftMake GMP-Ready Pharmaceutical 3D Printing Platform for Personalized Peptides Life Science Investing
